Medication info
Ultrafin Tablets

Ultrafin Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
SPC Co., Ltd.
Appearance
Light yellow, oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201503181 · Approved 2015.05.27 · Insurance code 669700190

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Older adults Administer the usual adult dose. However, since the elimination half-life of tramadol increases by 17% when tramadol is administered orally to older adults aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal failure For patients with moderate renal failure (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal failure (creatinine clearance below 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, this drug does not need to be readministered after dialysis to maintain its analgesic effect. Patients with hepatic failure Carefully consider extending the dosing interval in patients with moderate hepatic failure. Do not administer this drug to patients with severe hepatic failure.
Child dose
Children 12 years of age and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended; thereafter, doses should be taken at intervals of at least 6 hours, not exceeding 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term use is required because of the nature and severity of the condition, perform regular monitoring to determine whether treatment with this drug should be continued.

Ingredients

Manufacturer
SPC Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Older adults Administer the usual adult dose. However, since the elimination half-life of tramadol increases by 17% when tramadol is administered orally to older adults aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal failure For patients with moderate renal failure (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal failure (creatinine clearance below 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, this drug does not need to be readministered after dialysis to maintain its analgesic effect. Patients with hepatic failure Carefully consider extending the dosing interval in patients with moderate hepatic failure. Do not administer this drug to patients with severe hepatic failure.

Child dose

Children 12 years of age and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended; thereafter, doses should be taken at intervals of at least 6 hours, not exceeding 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term use is required because of the nature and severity of the condition, perform regular monitoring to determine whether treatment with this drug should be continued.

Precautions

This medication can burden the liver; therefore, individuals who regularly consume more than three alcoholic beverages daily should consult a physician or pharmacist before taking it. Although rare, severe skin allergic reactions may occur after taking this medication, so if any skin rash or hypersensitivity reaction occurs, it should be stopped immediately and a healthcare professional should be informed. The tramadol component in this medication may increase the risk of seizures, so caution is required for those with a history of seizures or who are taking medications that may induce seizures. Additionally, taking this medication with alcohol or other central nervous system depressants can lead to severe drowsiness, respiratory depression, or coma; therefore, it’s essential to consult a physician before combining them. For patients with acute bronchial asthma, this drug can worsen breathing difficulties, so it must be used in a monitored environment. This medication should not be administered to children, especially those under 12 years old or adolescents under 18 years old who have had tonsillectomy or adenoidectomy. Patients with severely impaired liver or kidney function should consult a physician before using this medication, and dosage adjustments may be necessary. This medication can cause drowsiness or dizziness; therefore, it's advisable to avoid driving or operating hazardous machinery while on this treatment. In case of overdose, serious side effects such as respiratory depression, seizures, and liver damage may occur, so adherence to the prescribed dosage and following the doctor's instructions is crucial. Pregnant or breastfeeding women should consult a healthcare professional before taking this medication, as it may affect the fetus or newborn. There may be potential drug interactions with this medication; therefore, inform healthcare professionals if taking other medications for safe usage. After use, store in a safe place out of reach of children to prevent accidental ingestion or misuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, fatal respiratory inhibition, hyponatremia, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremors, paresthesia, attention deficit, syncope, memory disorders, psychomotor agitation, sedation, amnesia, perceptual disturbances, seizures, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweats, urinary disturbances, erectile dysfunction, weakness, chest pain, emotional abnormalities, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, warmth, weight loss, increased serum creatinine, anaphylactic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, language disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, hyperglutaminemia, high anion gap metabolic acidosis, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exacerbation of migraine, involuntary muscle contractions, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urinary retention, increased urination, abnormal kidney function tests, oliguria, rash, increased sweating, urticaria, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, decreased appetite, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, increased white blood cells, thrombocytopenia, palpitations, exacerbation of hypertension, arrhythmias, aortic stenosis, bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, dizziness, confusion, dyspnea, migraine, language disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, indigestion, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly sealed container to prevent air exposure, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way maintains the medication’s efficacy for a longer period.

Appearance and packaging

Appearance

Light yellow, oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.